Skip to main content

Advertisement

SpringerLink
Log in

Gynecomastia

  • Review Article
  • Published:
Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Enlargement of breasts among boys is termed gynecomastia. This could be due to an alteration in the androgen-estrogen ratio along with the effects of other hormones including growth hormone, insulin like growth factor 1, prolactin, and other factors affecting aromatase enzyme. The common causes of gynecomastia are pubertal gynecomastia, obesity, drugs and hypogonadism. Several other diseases including liver or renal failure, thyrotoxicosis, Klinefelter syndrome, tumors and environmental pollutants can cause gynecomastia. History and clinical examination will help formulate targeted investigations and management. The factors to be evaluated in these include examination of breasts and testes, in addition to other parts of systemic examination. Treatment of underlying disorders can improve gynecomastia, such as use of testosterone in hypogonadism. Some boys may not need any intervention as gynecomastia may resolve on its own. Medical management is useful in simple gynecomastia. Tamoxifen has been tried successfully in adolescents with gynecomastia. Other drugs including clomiphene, danazol, letrozole and anastrozole have not been consistently useful in this age group. In severe chronic gynecomastia, surgery is the treatment of choice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Swerdloff RS, Ng JCM. Gynecomastia: Etiology, Diagnosis, and Treatment. [Updated 2023 Jan 6]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available at: https://www.ncbi.nlm.nih.gov/sites/books/NBK279105/.

  2. Kleinberg DL, Feldman M, Ruan W. IGF-1: an essential factor in terminal end bud formation and ductal morphogenesis. J Mammary Gland Biol Neoplasia. 2000;5:7–17.

    Article  CAS  PubMed  Google Scholar 

  3. Thompson DF, Carter JR. Drug-induced gynecomastia. Pharmacotherapy. 1993;13:37–45.

    Article  CAS  PubMed  Google Scholar 

  4. Braunstein GD. Gynecomastia. N Engl J Med. 2007;357:1229–37.

    Article  CAS  PubMed  Google Scholar 

  5. Cuhaci N, Polat SB, Evranos B, Ersoy R, Cakir B. Gynecomastia: clinical evaluation and management. Indian J Endocr Metab. 2014;18:150–8.

    Article  Google Scholar 

  6. Henley DV, Lipson N, Korach KS, Bloch CA. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med. 2007;356:479–85.

    Article  CAS  PubMed  Google Scholar 

  7. Bulard J, Mowszowicz I, Schaison G. Increased aromatase activity in pubic skin fibroblasts from patients with isolated gynecomastia. J Clin Endocrinol Metab. 1987;64:618–23.

    Article  CAS  PubMed  Google Scholar 

  8. Georgiadis E, Papandreou L, Evangelopoulou C, et al. Incidence of gynaecomastia in 954 young males and its relationship to somatometric parameters. Ann Hum Biol. 1994;21:579–87.

    Article  CAS  PubMed  Google Scholar 

  9. Cordova A, Moschella F. Algorithm for clinical evaluation and surgical treatment of gynaecomastia. J Plast Reconstr Aesthet Surg. 2008;61:41–9.

    Article  PubMed  Google Scholar 

  10. Reinehr T, Kulle A, Barth A, Ackermann J, Lass N, Holterhus PM. Sex hormone profile in pubertal boys with gynecomastia and pseudogynecomastia. J Clin Endocrinol Metab. 2020;105:dgaa044.

  11. Johnson RE, Murad MH. Gynecomastia: pathophysiology, evaluation, and management. Mayo Clin Proc. 2009;84:1010–5.

    Article  PubMed  PubMed Central  Google Scholar 

  12. König R, Schönberger W, Neumann P, Benes P, Grimm W. Treatment of marked gynecomastia in puberty with tamoxifen [In German]. Klin Padiatr. 1987;199:389–91.

    Article  PubMed  Google Scholar 

  13. Lawrence SE, Faught KA, Vethamuthu J, Lawson ML. Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr. 2004;145:71–6.

    Article  CAS  PubMed  Google Scholar 

  14. Mathur R, Braunstein GD. Gynecomastia: pathomechanisms and treatment strategies. Horm Res. 1997;48:95–102.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics and Pediatric Endocrinology, G. Kuppuswamy Naidu Memorial Hospital, Coimbatore, 641037, Tamil Nadu, India

    Ahila Ayyavoo

Authors
  1. Ahila Ayyavoo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahila Ayyavoo.

Ethics declarations

Conflict of Interest

None.

Guarantor

AA will act as the guarantor for this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 526 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ayyavoo, A. Gynecomastia. Indian J Pediatr 90, 1013–1017 (2023). https://doi.org/10.1007/s12098-023-04810-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-023-04810-7

Keywords

Search

Navigation